GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates

Sep.10
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
The Global State of Tobacco Harm Reduction, a project operated by Knowledge·Action·Change, estimates that about 200 million people worldwide use non-combustible nicotine products including vapes, heated tobacco, nicotine pouches and snus. Its 2026 report says use of these products rose alongside declining smoking rates in 28 countries it analyzed. The data do not establish that all 200 million users have quit smoking, nor do they prove a direct causal relationship. GSTHR also says regulatory restrictions on the products continue to expand in many markets.

Editor’s Note (September 14, 2026): This article has been updated to clarify different estimates for global heated tobacco product use cited across GSTHR publications. The 2026 Situation Report uses approximately 48.9 million as its primary estimate for HTP users in 2024, while related research produced higher estimates under alternative methodologies and a separate GSTHR 2026 briefing cited approximately 78 million users. The article has been revised to distinguish these different estimates and methodologies. 2Firsts thanks a reader for flagging the discrepancy.


Key Points

  • GSTHR estimates about 200 million people worldwide use what it terms “safer nicotine products,” including vapes, heated tobacco, nicotine pouches and snus.
  • The report says use of non-combustible products rose while smoking rates fell in 28 countries analyzed.
  • Global adult vaping users were estimated at about 129 million in 2025, while the GSTHR 2026 Situation Report gives a primary estimate of approximately 48.9 million heated tobacco product users in 2024. Other GSTHR materials have cited a higher estimate of around 78 million.
  • GSTHR is operated by Knowledge·Action·Change and funded by Global Action to End Smoking, whose predecessor historically received funding from Philip Morris International.

2Firsts

September 10, 2026

According to The Global State of Tobacco Harm Reduction 2026: A Situation Report, published by the Knowledge·Action·Change-operated Global State of Tobacco Harm Reduction project, about 200 million people worldwide now use non-combustible nicotine products including vapes, heated tobacco products, nicotine pouches and snus.

The report says use of these products has increased alongside declining smoking rates in 28 countries it analyzed, which GSTHR presents as evidence of a broader shift away from combustible tobacco.

About 200 Million Users Worldwide

GSTHR groups vaping products, heated tobacco, nicotine pouches and snus under what it calls “safer nicotine products.”

It estimates that about 200 million people globally use products within these categories.

That figure does not mean 200 million people have completely stopped smoking.

Some users may continue to smoke cigarettes while using other nicotine products, and there may also be overlap between product categories.

Media descriptions suggesting that “200 million people have said goodbye to cigarettes” therefore go beyond what the report itself can establish.

Global Vaping Users Estimated at 129 Million

Among the individual categories, vaping has one of the most developed global user estimates.

GSTHR cites research estimating that about 129 million adults worldwide used vaping products in 2025.

The estimate was published in the peer-reviewed journal Global Epidemiology.

For heated tobacco products, the GSTHR 2026 Situation Report gives a primary estimate of approximately 48.9 million users worldwide in 2024, with a range of 45.6 million to 52.1 million. Related peer-reviewed research produced higher estimates under alternative methodologies, and a separate GSTHR 2026 briefing cited approximately 78 million users.

GSTHR also notes that robust global estimates are not currently available for nicotine pouch and snus users. Category-specific figures should not be added directly because some consumers may use more than one type of product.

28 Countries Show Rising Use Alongside Falling Smoking Rates

GSTHR examined changes in non-combustible nicotine use and smoking prevalence across 28 countries.

The report says the markets showed a common pattern: use of vaping, heated tobacco or other non-combustible products increased while cigarette smoking rates declined.

GSTHR describes this pattern as a “scissor effect,” with the two trends moving in opposite directions.

The finding is observational, however.

The data do not by themselves establish that increased use of non-combustible products caused smoking rates to fall. Tobacco taxes, smoke-free laws, changing health behavior, demographics and other tobacco-control measures may also affect smoking prevalence.

GSTHR Says Regulation Is Tightening

The report also argues that growing consumer use of non-combustible nicotine products is occurring alongside tighter regulation in parts of the world.

GSTHR says some countries continue to prohibit vaping products, nicotine pouches or other alternatives while combustible cigarettes remain legally available.

Knowledge·Action·Change argues that such policies restrict adult smokers’ access to alternatives and calls for wider adoption of tobacco harm reduction policies.

Those conclusions reflect the policy position of GSTHR and its operator.

Funding and Organizational Background

GSTHR is operated by the U.K.-based public health organization Knowledge·Action·Change.

Its 2026 work is funded by Global Action to End Smoking.

Global Action to End Smoking was previously known as the Foundation for a Smoke-Free World and historically received funding from Philip Morris International.

Global Action says it has not accepted funding from tobacco or non-medicinal nicotine companies since 2023, while PMI has said its previous funding arrangement with the organization ended that year.

The World Health Organization has criticized the organization over its historical relationship with PMI and has advised public health bodies against engaging with it.

That funding history does not by itself invalidate the report’s underlying data, but it is relevant when distinguishing GSTHR’s policy conclusions from independent public health or government assessments.

Non-Combustible Nicotine Use Continues to Expand

Regardless of debate around the report’s policy recommendations, the compiled figures indicate that non-combustible nicotine products have established a substantial global user base.

Vaping now has an estimated 129 million adult users globally, while the GSTHR 2026 Situation Report puts heated tobacco product users at approximately 48.9 million under its primary estimate. Nicotine pouches continue to expand in markets including the United States and Europe.

For the industry, the next question is not only whether the user base continues to grow, but also whether regulatory access remains stable and whether long-term national data show sustained declines in cigarette use as alternative products expand.

GSTHR’s 28-country analysis adds another global dataset to that debate, while the relationship between product uptake and smoking decline remains a subject for further independent research.

Follow 2Firsts for timely updates on global tobacco and nicotine regulations, market developments and industry trends.

Cover Image: Global State of Tobacco Harm Reduction


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
2Firsts Data|China’s Vape-Related Exports Rose 3.3% in August 2026 as UK Shipments Jumped 51.4% and U.S. Exports Fell 12.4%
China exported $979 million of vape-related products in August 2026, up 3.3% from a year earlier but down 6.4% from July. The UK replaced the U.S. as the main source of growth: UK-bound shipments jumped 51.4% to a 2026 high of $177 million, while exports to the U.S. fell 12.4% to $339 million. Shipments to markets outside the U.S. increased 14.2%, broadening growth beyond the market that had driven July’s rebound.
News
Sep.23 by 2Firsts Perspectives